FindTrial
Sign In

Observational study.

OTHER5 trials

Sponsors

Kerman University of Medical Sciences, Oslo University Hospital, Oxford Brookes University, University Medical Center Groningen, Department of Neurology, the Netherlands

Conditions

1. PropofolChronic myeloid leukaemia (CML). Chronic myeloid leukaemia [CML], BCR/ABL-positiveColorectal CarcinomaMesotheliomaMultiple SclerosisNeuromyelitis OpticaOvarian CarcinomaPseudomyxoma Peritonei

Phase 4

Population Pharmacokinetics study of Imatinib
Active, not recruitingIRCT2014050612206N1
Kerman University of Medical SciencesChronic myeloid leukaemia (CML). Chronic myeloid leukaemia [CML], BCR/ABL-positive
Start: 2014-05-22Target: 220Updated: 2018-02-22

Unknown Phase

Pilot trial: Propofol in head-injured patients.
Active, not recruitingNL-OMON22558
University Medical Center Groningen, Department of Neurology, the Netherlands1. Propofol
Start: 2006-01-26Target: 10Updated: 2024-02-28
Peritoneal Surface Malignancies - Characterization, Models and Treatment Strategies
RecruitingNCT02073500
Oslo University HospitalColorectal Carcinoma, Mesothelioma, Ovarian Carcinoma +1
Start: 2009-09-30End: 2027-08-31Target: 300Updated: 2021-07-28
Locally Advanced Rectal Cancer - Exfoliated Peritoneal Tumor Cells
Active, not recruitingNCT02113384
Oslo University HospitalRectal Cancer
Start: 2012-09-30End: 2028-01-31Updated: 2021-07-28
Lifestyle Weight Management Program: Interviews and Stakeholder Meetings.
NCT05070286
Oxford Brookes UniversityMultiple Sclerosis, Neuromyelitis Optica
Start: 2022-01-01End: 2022-12-31Target: 45Updated: 2022-01-21

Related Papers

Peptide vaccine targeting mutated <i>GNAS</i>: a potential novel treatment for pseudomyxoma peritonei
Journal for ImmunoTherapy of Cancer2021-10-0126 citations